Featured Speakers
Every month, experts in prostate cancer share their time and expertise with us in online meetings that are intended for anyone who wants to learn more about prostate cancer: patients, partners, families, friends, and their medical teams. Speakers cover a wide range of prostate cancer topics, from testing and diagnosis to advances in treatment and living with your disease. Every live presentation is followed by Q&A.
Presentations are usually on the fourth Thursday of the month, with occasional "fireside chats" of about 20 minutes at the beginning of Tuesday support group meetings.
Most presentations are recorded and can be found in the Presentations Library.
Thursday, March 27, 2025
Hyperthermia for Prostate Cancer: an effective adjuvant therapy
Joseph J. Pinzone, MD, MBA, FACP
Imagine a non-invasive. FDA-approved cancer treatment that can help radiation and chemotherapy to work about 50 percent better. That's hyperthermia, an effective heat therapy which has been utilized for decades.
Dr. Joseph Pinzone is Chief Medical Officer of Hyperthermia Cancer Institute (HCI). He received his M.D. from NYU, completed residency in Internal Medicine at Columbia-Presbyterian Medical Center in N.Y. and fellowship in Endocrinology, Diabetes & Metabolism at Massachusetts General Hospital and Harvard Medical School where he secured an NIH grant to study pituitary tumors. He was on faculty at George Washington University School of Medicine and The Ohio State College of Medicine with a 5-year NIH grant to study breast cancer. Then at Amgen he was Director of Medical Affairs for the launch of XGEVAÒ a medication for patients with cancer and bone metastases. Dr. Pinzone has taught numerous students, physicians, & scientists and published scientific papers. He wrote & hosted a PBS TV show Innovation in Biologic and Biosimilar Medications and appeared multiple times on the CBS TV series The Doctors. He was previously Assistant Professor of Clinical Medicine at David Geffen School of Medicine at UCLA.
Tuesday, April 1, 2025
The Power of Precision:
How Theranostics and PET/CT Imaging Are Revolutionizing Prostate Cancer Diagnosis and Treatment
Jeremie Calais, MD, PhD
Associate Professor, Department of Molecular and Medical Pharmacology
Since Dr. Calais last spoke to us abaout a year ago, Theranostics - advanced imaging followed by targeted therapies - continues to advance, bringing insight, precision, and hope to the treatment of prostate cancer. Dr. Calais brings us up to date so that patients can be informed partners with their medical teams.
Dr. Jeremie Calais' work focuses on improving the outcomes of cancer patients by translating and applying novel diagnostic and therapeutic approaches. He uses Positron Emission Tomography/Computed Tomography (PET/CT) imaging for cancer phenotyping, radiation therapy planning and therapy response assessment. He leads the clinical theranostics research program at UCLA that combines radionuclide therapy and imaging.
Thursday, May 22, 2025
When You Can See More, You Can Do More - Micro-Ultrasound for Prostate Cancer Imaging
Micro-Ultrasound is a new imaging technology specifically designed for the Prostate. This technology combines the real-time imaging of ultrasound with a sensitivity previously only possible using MRI, and opens up new possibilities for Prostate Cancer diagnosis and treatment. We will review the technology, along with recent clinical data, and how it is changing practice.
Brian is a post-doctoral level biomedical engineer with 15 years’ experience in medical devices and biomedical research. Brian is VP of Engineering and Clinical at Exact Imaging, responsible for overseeing product development, clinical applications, physician training, and clinical evidence generation.
Prior to Exact Imaging, Brian held research positions at the University of Pittsburgh Medical Center and Case Western Reserve University. This research won Popular Mechanics Top Breakthroughs of the Year award and has been featured in the popular media on platforms such as CBS's "60 Minutes". Brian holds 9 patents in the medical devices space, has designed and executed more than 13 clinical trials and has authored more than 23 peer-reviewed research articles in prestigious journals such as The Lancet, and PLoS ONE.
Brian holds a PhD and MSc in Biomedical Engineering from Case Western Reserve University and BASc in Engineering Science from the University of Toronto.